Eltrombopag

Eltrombopag · Thrombopoietin receptor agonist

Chronic immune thrombocytopenia, severe aplastic anemia, thrombocytopenia with chronic hepatitis C

25/50/75mg tablets Once daily oral Insurance Category B

Therapeutic Areas

Hematology

Marketed Products

Eltrombopag

Modality

Eltrombopag

Core Products

Imatinib · BCR-ABL tyrosine kinase inhibitor

Rivaroxaban · Oral factor Xa inhibitor

Romiplostim · Fc fusion protein TPO receptor agonist

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide